Skip to main content

Regulatory & Access Resources

Browse our regulatory & access resources to find the latest articles, blogs, brochures, and videos from our experts. See the latest content below.

Getting to ‘No’ fast is more important when you are small

Drug development is a complex business. Historically, less than 8% of product candidates are reported to have made it from Phase I to market. One effective way to mitigate risk is to weed out weak and average product candidates and focus resources on lead products and follow-ons with the best chances of success. This blog looks at helpful strategies to identify winners and losers.